Oxford Nanopore at AACR 2026
Oxford Nanopore will be at the AACR Annual Meeting at Booth 2221 in April, 2026, hosted in San Diego. We will also host a Exhibitor Spotlight Theater on Monday, April 20. See additional details below.
Spotlight Theater
Accelerating precision oncology: Real-time genomic and epigenomic profiling with Oxford Nanopore
sequencing
Date: Monday, April 20
Time: 12:30-1:30 PM PST
Location: Exhibit Hall, Theater C
This industry-sponsored session will highlight how real-time Oxford Nanopore sequencing is transforming precision oncology through rapid genomic and epigenomic profiling. Dr. Parth S. Shah (Geisel School of Medicine at Dartmouth) will present his approach to accelerating the diagnosis and molecular characterization of hematologic malignancies using nanopore sequencing. Dr. Bastiaan Tops (Prinscess Maxima Center) will showcase a rapid, methylation-based classification workflow for CNS tumors.
Together, these presentations will demonstrate how rapid molecular insights can be leveraged to inform clinical decision-making and advance time-critical cancer care.
Speaker details and registration coming soon.
Ellie Juarez
- Job title
- Associate Director, Segment Marketing – Oncology
- Institution
- Oxford Nanopore Technologies
- Biography
Eleonora (Ellie) Juarez is currently the market segment manager for Oncology at Oxford Nanopore Technologies. With her extensive cancer genomics experience and a doctorate in molecular and medical genetics, she drives the development of new oncology assays, enabling cancer researchers to answer the most complex biological questions using nanopore sequencing. Juarez has held leadership roles at Twinstrand Biosciences, Integrated DNA Technologies (IDT), and Twist Bioscience, where she significantly contributed to product and application development and corporate strategy.
Bastiaan Tops
- Job title
- Head of the Laboratory of Childhood Cancer Pathology
- Institution
- Princess Maxima Center
- Biography
Dr. Jose Alexander obtained his medical degree from the Central University of Venezuela and trained as a Medical & Public Health Microbiologist.
Dr. Alexander is board certified by the American Board of Medical Microbiology (ABMM) and a Fellow from the Canadian College of Microbiologists; he also is certified as Specialist in Microbiology and Molecular Biologist by the American Society for Clinical Pathologists (ASCP). Dr Alexander is Board Certified in Infection Control and Epidemiology (CBIC) and Board-Certified Medical Affairs Specialist by the American Council for Medical Affairs (ACMA).
He currently is the Clinical & Technical Director of the Microbiology, Virology, and Immunology Laboratories at AdventHealth Orlando.
His main area of experience is in antimicrobial resistance, implement of next-generation sequencing, and data-driven lab optimization protocols.
Single day profiling of Acute Myeloid Leukemia Parth Shah
- Job title
- Director of Genome Informatics
- Institution
- Geisel School of Medicine at Dartmouth
- Biography
Parth Shah, MD is a physician scientist and the Director of Genome Informatics at Dartmouth Hitchcock Medical Center. He has led the development of the Dartmouth Cloud and the development of the AUGMET application at Dartmouth which is a HIPAA compliant multiomics enviroment for research and development. He has since led the development and deployment of clinical somatic exome and transcriptome sequencing for all solid and hematological malignancies at the Dartmouth Cancer Center. He is an Assistant Professor in Medicine, Pathology and Laboratory medicine at the Geisel School of Medicine at Dartmouth. He earned his medical degree from NHL Municipal Medical College in Ahmedabad, completed his residency at Beth Israel Lahey Health, and pursued fellowships at both the Dana-Farber Cancer Institute and Dartmouth Hitchcock Medical Center.
